United Kingdom · Series B startup
5 rounds we have observed, with the 15 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised this month
Follow T-Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 7 Nov 2026
$279Mraised across 5 rounds since 2024, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
British Business BankLead
Advent Life Sciences LlpLead
Tengxun Touzi
Business Growth Fund
Sofinnova Partners
F-Prime Capital
Eli Lilly
Samsara BioCapital
Digitalis Ventures
Cambridge Innovation Capital
Johnson & Johnson Robotics and Digital Solutions
M/VENTURES
Sanofi VenturesReported by Advent Life Sciences Llp and 2 others
Reported by Silicon Canals
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
T-Therapeutics filed 4 raises, $76M in all. Filings say how much was sold and to how many investors; they never name the investors.
From T-Therapeutics's own website: 7 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Tengxun TouziBusiness Growth FundSofinnova PartnersDigitalis VenturesBritish Business BankLAdvent Life Sciences LlpLF-Prime CapitalEli LillySamsara BioCapital
SanofiMissing a round, or an investor who was in one? Tell us.
T-Therapeutics's investors include Tengxun Touzi, Business Growth Fund, Sofinnova Partners, Digitalis Ventures and British Business Bank, and 10 more on record. British Business Bank led its latest round.
T-Therapeutics has raised $279M across 5 rounds since 2024.
T-Therapeutics's most recent round was a Series B of $133M in Nov 2026, led by British Business Bank.
Its most recent round, $133M in Nov 2026, is also its largest on record.
T-Therapeutics's first round on record, in Nov 2025, was backed by Tengxun Touzi, Business Growth Fund and Sofinnova Partners and 2 others.
T-Therapeutics's latest named round is a Series B, in Nov 2026.
T-Therapeutics is based in the United Kingdom.
British Business Bank led the Series B in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
